Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease.

Gilbert NM, O'Brien VP, Lewis AL.

PLoS Pathog. 2017 Mar 30;13(3):e1006238. doi: 10.1371/journal.ppat.1006238. eCollection 2017 Mar.

2.

Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.

Walters MS, Lane MC, Vigil PD, Smith SN, Walk ST, Mobley HL.

MBio. 2012 Feb 7;3(1). pii: e00303-11. doi: 10.1128/mBio.00303-11. Print 2012.

3.

Detection of intracellular bacterial communities in human urinary tract infection.

Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ.

PLoS Med. 2007 Dec;4(12):e329.

4.

Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.

Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, Binkley J, Dodson K, Raivio TL, Hultgren SJ.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E871-80. doi: 10.1073/pnas.1500374112. Epub 2015 Feb 9.

5.

A Murine Model for Escherichia coli Urinary Tract Infection.

Hannan TJ, Hunstad DA.

Methods Mol Biol. 2016;1333:159-75. doi: 10.1007/978-1-4939-2854-5_14.

6.
7.

Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.

Michaud JE, Kim KS, Harty W, Kasprenski M, Wang MH.

BMC Microbiol. 2017 May 25;17(1):127. doi: 10.1186/s12866-017-1036-0.

8.

Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells.

Dikshit N, Bist P, Fenlon SN, Pulloor NK, Chua CE, Scidmore MA, Carlyon JA, Tang BL, Chen SL, Sukumaran B.

PLoS Pathog. 2015 Aug 6;11(8):e1005083. doi: 10.1371/journal.ppat.1005083. eCollection 2015 Aug.

9.
10.

Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.

Schwartz DJ, Conover MS, Hannan TJ, Hultgren SJ.

PLoS Pathog. 2015 Jan 8;11(1):e1004599. doi: 10.1371/journal.ppat.1004599. eCollection 2015 Jan.

11.

Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.

Conover MS, Hadjifrangiskou M, Palermo JJ, Hibbing ME, Dodson KW, Hultgren SJ.

MBio. 2016 Apr 12;7(2):e00104-16. doi: 10.1128/mBio.00104-16.

12.

Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.

Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL.

Infect Immun. 2012 Dec;80(12):4186-94. doi: 10.1128/IAI.00684-12. Epub 2012 Sep 17.

13.

Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.

Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8829-35. Review.

14.

Vaginal microbiota of spayed dogs with or without recurrent urinary tract infections.

Hutchins RG, Vaden SL, Jacob ME, Harris TL, Bowles KD, Wood MW, Bailey CS.

J Vet Intern Med. 2014 Mar-Apr;28(2):300-4. doi: 10.1111/jvim.12299. Epub 2014 Jan 27.

15.

Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.

Schwartz DJ, Chen SL, Hultgren SJ, Seed PC.

Infect Immun. 2011 Oct;79(10):4250-9. doi: 10.1128/IAI.05339-11. Epub 2011 Aug 1.

16.

Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.

Danka ES, Hunstad DA.

J Infect Dis. 2015 Apr 1;211(7):1164-73. doi: 10.1093/infdis/jiu577. Epub 2014 Oct 21.

17.

Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.

Bokil NJ, Totsika M, Carey AJ, Stacey KJ, Hancock V, Saunders BM, Ravasi T, Ulett GC, Schembri MA, Sweet MJ.

Immunobiology. 2011 Nov;216(11):1164-71. doi: 10.1016/j.imbio.2011.05.011. Epub 2011 May 24.

PMID:
21802164
18.

Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.

Guiton PS, Cusumano CK, Kline KA, Dodson KW, Han Z, Janetka JW, Henderson JP, Caparon MG, Hultgren SJ.

Antimicrob Agents Chemother. 2012 Sep;56(9):4738-45. doi: 10.1128/AAC.00447-12. Epub 2012 Jun 25.

19.

A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease.

O'Brien VP, Hannan TJ, Yu L, Livny J, Roberson ED, Schwartz DJ, Souza S, Mendelsohn CL, Colonna M, Lewis AL, Hultgren SJ.

Nat Microbiol. 2016 Oct 31;2:16196. doi: 10.1038/nmicrobiol.2016.196.

20.

Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.

Anderson GG, Dodson KW, Hooton TM, Hultgren SJ.

Trends Microbiol. 2004 Sep;12(9):424-30. Review.

PMID:
15337164

Supplemental Content

Support Center